Basic Information
RNALocate ID: | RLID:11002475 |
RNA Symbol: | hsa-miR-370-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-370 |
RNA ID: | miRBase:MIMAT0000722 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002029 | Cytoplasm | Cervical cancer cell lines (HeLa|SiHa) | 31703640 |
RLID:01002030 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002472 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
RLID:11002473 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11002474 | Exosome | Brain tissue | 23382797 |
RLID:11002476 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000412 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001200 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-370-3p | Oral squamous cell carcinoma | MNDR-E-MI-44981 |
MNDR | hsa-miR-370-3p | Medulloblastoma | MNDR-E-MI-44982 |
MNDR | hsa-miR-370-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-44983 |
MNDR | hsa-miR-370-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-44984 |
MNDR | hsa-miR-370-3p | Lymphoma | MNDR-E-MI-44985 |
MNDR | hsa-miR-370-3p | Non-hodgkin lymphoma | MNDR-E-MI-44986 |
MNDR | hsa-miR-370-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-44987 |
MNDR | hsa-miR-370-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-44988 |
MNDR | hsa-miR-370-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-44989 |
MNDR | hsa-miR-370-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-44990 |
MNDR | hsa-miR-370-3p | Her2-receptor positive breast cancer | MNDR-E-MI-44991 |
MNDR | hsa-miR-370-3p | Anencephaly | MNDR-E-MI-44992 |
MNDR | hsa-miR-370-3p | Neurofibromatosis 1 | MNDR-E-MI-44993 |
MNDR | hsa-miR-370-3p | Dermatomyositis | MNDR-E-MI-44994 |
MNDR | hsa-miR-370-3p | Prostate cancer | MNDR-E-MI-44995 |
MNDR | hsa-miR-370-3p | Gastric cancer | MNDR-E-MI-44996 |
MNDR | hsa-miR-370-3p | Alzheimer disease | MNDR-E-MI-44997 |
MNDR | hsa-miR-370-3p | Intracranial aneurysm | MNDR-E-MI-44998 |
MNDR | hsa-miR-370-3p | Dysautonomia familial | MNDR-E-MI-44999 |
MNDR | hsa-miR-370-3p | Brain cancer | MNDR-E-MI-45000 |
MNDR | hsa-miR-370-3p | Lung cancer | MNDR-E-MI-45001 |
MNDR | hsa-miR-370-3p | Parkinson disease | MNDR-E-MI-45002 |
MNDR | hsa-miR-370-3p | Breast cancer | MNDR-E-MI-45003 |
MNDR | hsa-miR-370-3p | Pituitary neoplasms | MNDR-E-MI-45004 |
MNDR | hsa-miR-370-3p | Pancreatic cancer | MNDR-E-MI-45005 |
MNDR | hsa-miR-370-3p | Rectum adenocarcinoma | MNDR-E-MI-45006 |
MNDR | hsa-miR-370-3p | Colon cancer | MNDR-E-MI-45007 |
MNDR | hsa-miR-370-3p | Colon adenocarcinoma | MNDR-E-MI-45008 |
MNDR | hsa-miR-370-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45009 |
MNDR | hsa-miR-370-3p | Ovarian cancer | MNDR-E-MI-45010 |
MNDR | hsa-miR-370-3p | Prostate adenocarcinoma | MNDR-E-MI-45011 |
MNDR | hsa-miR-370-3p | Carcinoma ductal breast | MNDR-E-MI-45012 |
MNDR | hsa-miR-370-3p | Glioblastoma | MNDR-E-MI-45013 |
MNDR | hsa-miR-370-3p | Glioma | MNDR-E-MI-45014 |
MNDR | hsa-miR-370-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-45015 |
MNDR | hsa-miR-370-3p | Osteosarcoma | MNDR-E-MI-45016 |
MNDR | hsa-miR-370-3p | Coronary artery disease | MNDR-E-MI-45017 |
MNDR | hsa-miR-370-3p | Meningioma | MNDR-E-MI-45018 |
MNDR | hsa-miR-370-3p | Cervical adenocarcinoma | MNDR-E-MI-45019 |
MNDR | hsa-miR-370-3p | Cervical squamous cell carcinoma | MNDR-E-MI-45020 |
MNDR | hsa-miR-370-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-45021 |
MNDR | hsa-miR-370-3p | Lung squamous cell carcinoma | MNDR-E-MI-45022 |
MNDR | hsa-miR-370-3p | Carcinoma lung non-small-cell | MNDR-E-MI-45023 |
MNDR | hsa-miR-370-3p | Lung adenocarcinoma | MNDR-E-MI-45024 |
MNDR | hsa-miR-370-3p | Adrenocortical carcinoma | MNDR-E-MI-45025 |
MNDR | hsa-miR-370-3p | Ovarian carcinoma | MNDR-E-MI-45026 |
MNDR | hsa-miR-370-3p | Bladder urothelial carcinoma | MNDR-E-MI-45027 |
MNDR | hsa-miR-370-3p | Pancreatic adenocarcinoma | MNDR-E-MI-45028 |
MNDR | hsa-miR-370-3p | Carcinoma renal cell | MNDR-E-MI-45029 |
MNDR | hsa-miR-370-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45030 |
MNDR | hsa-miR-370-3p | Renal clear cell carcinoma | MNDR-E-MI-45031 |
MNDR | hsa-miR-370-3p | Biliary tract cancer | MNDR-E-MI-45032 |
MNDR | hsa-miR-370-3p | Cholangiocarcinoma | MNDR-E-MI-45033 |
MNDR | hsa-miR-370-3p | Esophageal cancer | MNDR-E-MI-45034 |
MNDR | hsa-miR-370-3p | Synovial sarcoma | MNDR-E-MI-45035 |
MNDR | hsa-miR-370-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-45036 |
MNDR | hsa-miR-370-3p | Breast invasive carcinoma | MNDR-E-MI-45037 |
MNDR | hsa-miR-370-3p | Hepatocellular carcinoma | MNDR-E-MI-45038 |
MNDR | hsa-miR-370-3p | B-cell non-hodgkin lymphoma | MNDR-E-MI-45039 |
MNDR | hsa-miR-370-3p | Retinoblastoma | MNDR-E-MI-45040 |
MNDR | hsa-miR-370-3p | Chronic fatigue syndrome | MNDR-E-MI-45041 |
MNDR | hsa-miR-370-3p | Hodgkin disease | MNDR-E-MI-45042 |
MNDR | hsa-miR-370-3p | Acute myeloid leukemia | MNDR-E-MI-45043 |
MNDR | hsa-miR-370-3p | Colorectal cancer | MNDR-E-MI-45044 |
MNDR | hsa-miR-370-3p | Nasopharynx carcinoma | MNDR-E-MI-45045 |
MNDR | hsa-miR-370-3p | Multiple myeloma | MNDR-E-MI-45046 |
MNDR | hsa-miR-370-3p | Nasopharyngeal cancer | MNDR-E-MI-45047 |
MNDR | hsa-miR-370-3p | Prostatic neoplasms | MNDR-E-MI-45048 |
MNDR | hsa-miR-370-3p | Stroke lacunar | MNDR-E-MI-45049 |
MNDR | hsa-miR-370-3p | Breast cancer her3+ negative | MNDR-E-MI-45050 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CCNE2 | Homo sapiens | RR00295455 |
TOP